Featured Research

from universities, journals, and other organizations

Whooping Cough: Adults Can Fall Severely Ill To Pertussis Too

Date:
September 25, 2008
Source:
Deutsches Aerzteblatt International
Summary:
Pertussis, also known as whooping cough, is not just a childhood disease. The pathogen Bordetella pertussis is highly infectious and an infection may occur at any age. The risk of a pertussis infection can be greatly reduced by vaccination.

Pertussis, also known as whooping cough, is not just a childhood disease. The pathogen Bordetella pertussis is highly infectious and an infection may occur at any age. The risk of a pertussis infection can be greatly reduced by vaccination, as Marion Riffelmann of the Krefeld Institute for Infectious Diseases and her colleagues report in a recent report.*

Pertussis is actually one of the classical diseases of childhood and mainly occurs in unvaccinated babies. The clinical course at this age may be severe; pertussis is the most frequent fatal infectious disease in newborns.

Nevertheless, the number of reported attacks of whooping cough in schoolchildren, adolescents and adults has markedly increased in recent years. Roughly 0.2% to 0.5% of adolescents and adults fall ill each year with pertussis and a protracted cough. About 25% of adult patients develop complications, such as seizures, inflammation of the middle ear or circulatory collapse.

Although the standard treatment with macrolide antibiotics interrupts the chain of infection, it does not influence the symptoms. According to Riffelmann et al., the most effective pertussis prophylaxis is vaccination with a combination vaccine. However, regular boosters are needed, as the vaccination protection continuously decreases after five years.

*This research is published in the current Deutsches Δrzteblatt International (Dtsch Arztebl Int 2008; 105(37): 623-8).


Story Source:

The above story is based on materials provided by Deutsches Aerzteblatt International. Note: Materials may be edited for content and length.


Cite This Page:

Deutsches Aerzteblatt International. "Whooping Cough: Adults Can Fall Severely Ill To Pertussis Too." ScienceDaily. ScienceDaily, 25 September 2008. <www.sciencedaily.com/releases/2008/09/080925083201.htm>.
Deutsches Aerzteblatt International. (2008, September 25). Whooping Cough: Adults Can Fall Severely Ill To Pertussis Too. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/09/080925083201.htm
Deutsches Aerzteblatt International. "Whooping Cough: Adults Can Fall Severely Ill To Pertussis Too." ScienceDaily. www.sciencedaily.com/releases/2008/09/080925083201.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins